Metrics other than potency reveal systematic variation in responses to cancer drugs - Dataset (ID:20120)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10344-1 | Olomoucine II | LSM-6356 |  | 10067756 | |
| 10035-2 | Sigma A6730 | KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor | LSM-1035 |  | 10196499 |
| 10283-1 | XRP44X | AG-G-87906 | LSM-4298 |  | 10339779 |
| 10276-1 | TCS 2312 | LSM-6362 |  | 11258443 | |
| 10268-1 | Nutlin 3a | LSM-6351 |  | 11433190 | |
| 10142-2 | Trametinib | GSK-1120212; GSK1120212; GSK1120212B; JTP-74057 | LSM-1143 |  | 11707110 |
| 10098-2 | Gefitinib | ZD1839; Iressa | LSM-1098 |  | 123631 |
| 10230-2 | Lestaurtinib | CEP-701 | LSM-1231 |  | 126565 |
| 10026-3 | PD173074 | LSM-1026 |  | 1401 | |
| 10247-1 | Docetaxel | Taxotere | LSM-6360 |  | 148124 |
| 10277-1 | Temsirolimus | LSM-4295 |  | 148191 | |
| 10236-1 | 17-AAG | Tanespimycin | LSM-43239 |  | 151069 |
| 10013-3 | GSK461364 | GSK461364A | LSM-1013 |  | 15983966 |
| 10265-1 | Pevonedistat | MLN 4924; MLN-4924; MLN4924 | LSM-6263 |  | 16720766 |
| 10097-3 | Erlotinib | OSI-774 | LSM-1097 |  | 176870 |
| 10237-1 | 5-DFUR | 5-FdUR; Doxifluridine | LSM-6359 |  | 18343 |
| 10223-2 | AG1478 | Tyrphostin | LSM-1224 |  | 2051 |
| 10261-1 | Ixabepilone | Azaepothilone B; Ixempra | LSM-43293 |  | 216344 |
| 10146-2 | Omipalisib | GSK2126458; GSK2126458A | LSM-1147 |  | 25167777 |
| 10255-1 | GSK1838705A | LSM-4276 |  | 25182616 | |
| 10175-3 | Sunitinib | Sutent; SU11248 | LSM-42800 |  | 3086686 |
| 10248-1 | Doxorubicin | Adriamycin | LSM-4062 |  | 31703 |
| 10238-1 | 5-FU | Fluorouracil | LSM-4261 |  | 3385 |
| 10346-1 | Valproic acid | Depakine | LSM-4620 |  | 3549980 |
| 10250-1 | Etoposide | LSM-6348 |  | 36462 |